カタログ製品コード : C-EK22082
Mouse TRANCE/TNFSF11/RANKL ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK22082
Mouse TRANCE/TNFSF11/RANKL ELISA kit
24T | ¥55,200 | (¥2,300/T) (税別) |
48T | ¥69,200 | (¥1,442/T) (税別) |
96T | ¥78,000 | (¥813/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | TRANCE/TNFSF11/RANKL | Mouse | 31.25 - 2000 pg/ml | 20 μl | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against IL-22 |
Mouse IL-22 Standard, lyophilized |
IL-22 Detect Antibody |
Standard Diluent |
Streptavidin-HRP |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
washing Buffer (20×) |
Plate Covers |
■キーワード :
Mus musculus,Mouse,Tumor necrosis factor ligand superfamily member 11,Ly109l,ODF,OPGL,RANKL,Trance
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse TRANCE. The Mouse TRANCE/TNFSF11/RANKL ELISA is for research use only. Not for diagnostic or therapeutic procedures.
TNF-related activation-induced cytokine (TRANCE), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), receptor activator of nuclear factor kappa-B ligand (RANKL), is a member of the TNF superfamily. Cells known to express TRANCE include osteoblasts, CD4+ and CD8+ T cells, megakaryocytes, bronchial and intestinal epithelium and so on.
TRANCE appears to play a central role in both immune response and bone morphogenesis. During bone development and remodeling, TRANCE expression by osteoblasts in conjunction with M-CSF induces osteoclast formation and activation, resulting in bone resorption. This allows for subsequent bone deposition and remodeling. TRANCE also plays a role in pathological osteoporosis. Its inappropriate expression by activated lymphocytes and osteoblasts results in excessive joint and bone resorption vs. deposition. Overproduction of TRANCE is implicated in a variety of degenerative bone diseases, such as rheumatoid arthritis and psoriatic arthritis.